Damora Therapeutics, Inc. (DMRA) stock
DMRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$22.50+0.89 (+4.14%)
Close on Nov 16, 2026Market cap $1.39BP/E 5.7Yield 0.00%
Damora Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
No profit margin figures for Damora Therapeutics
Damora Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?